The effect of postoperative TACE on prognosis of HCC with microscopic venous invasion

Hepato-Gastroenterology

Volumn 59, Issue 118, 2012, Pages 1944-1946

  Li, Ke Wei ^a   Wen, Tian Fu ^a   Li, Xi ^a   Yan, Lü Nan ^a   Li, Bo ^b   Zeng, Yong ^a   Lu, Wu Sheng ^a   Wang, Wen Tao ^a   Xu, Ming Qing ^a   Yang, Jia Yin ^a   Ma, Yu Kui ^a   Chen, Zhe Yu ^a  

^a SICHUAN UNIVERSITY   (China)

^b NONE

Author keywords

Hepatectomy; Hepatocellular carcinoma; Microscopic venous invasion; Transcatheter arterial chemoembolization

Indexed keywords

EPIRUBICIN; FLOXURIDINE; IODINATED POPPYSEED OIL;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER INVASION; CHEMOEMBOLIZATION; DISEASE FREE SURVIVAL; FEMALE; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MICROSCOPIC VENOUS INVASION; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL; THERAPY EFFECT; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADULT; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; CHINA; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VEINS;

EID: 84867702720     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge11845     Document Type: Article

References (22)

1. Ren ZG, Lin ZY, Xia JL, et al.: Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: a retrospective control study. World J Gastroenterol 2004; 10:2791-2794.
2. Zhou WP, Lai EC, Li AJ, et al.: A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma. Ann Surg 2009; 249:195-202.
3. Belghiti J: Surgical treatment In: Lau WY, ed. Hepatocellular Carcinoma. Singapore: World Scientific Publishing Co Ltd; 2008:387-408.
4. Sasaki A, Iwashita Y, Shibata K, et al.: Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma. Eur J Surg Oncol 2006; 32:773-779. (Pubitemid 44276006)
5. Cheng HY, Wang X, Chen D, Xu AM, Jia YC: The value and limitation of transcatheter arterial chemoembolization in preventing recurrence of resected hepatocellular carcinoma. World J Gastroenterol 2005; 11:3644-3646.
6. Tsai TJ, Chau GY, Lui WY, et al.: Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 2000; 127:603-608.
7. Shirabe K, Kajiyama K, Harimoto N, et al.: Prognosis of hepatocellular carcinoma accompanied by microscopic portal vein invasion. World J Gastroenterol 2009; 15:2632-2637.
8. Ramsey DE, Kernagis LY, Soulen MC, Geschwind JF: Chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol 2002; 13:S211-221.
9. Konno T: Targeting cancer chemotherapeutic agents by use of lipiodol contrast medium. Cancer 1990; 66:1897-1903.
10. Egawa H, Mori K, Mitsuhashi S, et al.: Effects of intra-arterial chemotherapy using the new lipophilic anticancer agent 'KM2210' (estradiol-chlorambucil) dissolved in lipiodol on Walker 256 carcinosarcoma in Wistar rats-a preliminary report. Eur Surg Res 1990; 22:219-223. (Pubitemid 20350561)
11. Nakamura H, Hashimoto T, Oi H, Sawada S: Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 1989; 170:783-786. (Pubitemid 19062602)
12. Sasaki Y, Imaoka S, Kasugai H, et al.: A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge. Cancer 1987; 60:1194-1203. (Pubitemid 17152894)
13. Sergio A, Cristofori C, Cardin R, et al.: Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness. Am J Gastroenterol 2008; 103:914-921. (Pubitemid 351506379)
14. Bruix J, Sherman M: Management of hepatocellular carcinoma. Hepatology 2005; 42:1208-1236. (Pubitemid 43112690)
15. Mathurin P, Raynard B, Dharancy S, et al.: Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma. Aliment Pharmacol Ther 2003; 17:1247-1261. (Pubitemid 36693726)
16. Fan J, Zhou J, Wu ZQ, et al.: Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol 2005; 11:1215-1219. (Pubitemid 40353011)
17. Peng BG, He Q, Li JP, Zhou F: Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus. Am J Surg 2009; 198:313-318.
18. Izumi R, Shimizu K, Iyobe T, et al.: Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma. Hepatology 1994; 20:295-301. (Pubitemid 24233352)
19. Lai EC, Lo CM, Fan ST, Liu CL, Wong J: Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial. Arch Surg 1998; 133:183-188. (Pubitemid 28092919)
20. Sun HC, Tang ZY: Preventive treatments for recurrence after curative resection of hepatocellular carcinoma-a literature review of randomized control trials. World J Gastroenterol 2003; 9:635-640.
21. Ono T, Yamanoi A, Nazmy El Assai O, Kohno H, Nagasue N: Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: meta-analysis of three randomized controlled trials. Cancer 2001; 91:2378-2385. (Pubitemid 32552825)
22. Liu YM, Qin H, Wang CB, Fang XH, Ma QY: Comparison of therapeutic effectiveness of combined interventional therapy for 1126 cases of primary liver cancer. World J Gastroenterol 2006; 12:5060-5063. (Pubitemid 44323280)